BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17581392)

  • 1. Which is the right antibiotic treatment for ventilator-associated pneumonia?
    Corona A
    Crit Care Med; 2007 Jul; 35(7):1808; author reply 1808-9. PubMed ID: 17581392
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
    Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
    Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia.
    Arya SC; Agarwal N
    J Trauma; 2007 Oct; 63(4):962. PubMed ID: 18090032
    [No Abstract]   [Full Text] [Related]  

  • 4. Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?
    Pea F; Viale P
    J Trauma; 2009 Oct; 67(4):893-4; author reply 894-5. PubMed ID: 19820604
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the adequacy of empirical beta-lactam therapy for Pseudomonas aeruginosa ventilator-associated pneumonia.
    Depuydt P; Blot S; Benoit D; Decruyenaere J
    Int J Antimicrob Agents; 2008 May; 31(5):489-90. PubMed ID: 18313271
    [No Abstract]   [Full Text] [Related]  

  • 6. Empiric antibiotic therapy for suspected ventilator-associated pneumonia.
    Dotson B; Ohlinger MJ
    Crit Care Med; 2008 May; 36(5):1696-7. PubMed ID: 18448959
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic therapy for ventilator-associated pneumonia: de-escalation in the real world.
    Depuydt P; Blot S
    Crit Care Med; 2007 Feb; 35(2):632-3. PubMed ID: 17251705
    [No Abstract]   [Full Text] [Related]  

  • 8. Concerns regarding the methodology of the study entitled "Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?".
    Suzuki H; Kagawa H; Iwata K
    J Trauma; 2009 Nov; 67(5):1133; author reply 1133-4. PubMed ID: 19901690
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventilator-associated pneumonia in long-term ventilator-assisted individuals.
    García-Leoni ME; Moreno S; García-Garrote F; Cercenado E
    Spinal Cord; 2010 Dec; 48(12):876-80. PubMed ID: 20404831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic selection is crucial for optimal empiric monotherapy of ventilator-associated pneumonia.
    Cunha BA
    Crit Care Med; 2007 Aug; 35(8):1992-4. PubMed ID: 17667252
    [No Abstract]   [Full Text] [Related]  

  • 11. How can earlier antibiotic efficacy be provided for ventilator-associated pneumonia without promoting bacterial resistance? Is initial monotherapy or a combination of antibiotics the right answer?
    Papazian L
    Crit Care Med; 2008 Mar; 36(3):994-5. PubMed ID: 18431296
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of ventilator-associated pneumonia.
    Diaz E; Ulldemolins M; Lisboa T; Rello J
    Infect Dis Clin North Am; 2009 Sep; 23(3):521-33. PubMed ID: 19665081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing ventilator-associated pneumonia.
    Wood GC; Swanson JM
    AACN Adv Crit Care; 2009; 20(4):309-16; quiz 317-8. PubMed ID: 19893366
    [No Abstract]   [Full Text] [Related]  

  • 14. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 15. Moving towards real-time antimicrobial management of ventilator-associated pneumonia.
    Kollef MH
    Clin Infect Dis; 2007 Feb; 44(3):388-90. PubMed ID: 17205446
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
    Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 18. Tigecycline use in critically ill older patients: case reports and critical analysis.
    Curcio D; Fernández F; Duret F
    J Am Geriatr Soc; 2007 Feb; 55(2):312-3. PubMed ID: 17302676
    [No Abstract]   [Full Text] [Related]  

  • 19. Agreement with antimicrobial management for pseudomonal ventilator-associated pneumonia.
    Peeters MJ; Seifert CF
    Crit Care Med; 2007 Dec; 35(12):2882. PubMed ID: 18043221
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of aerosolized antibiotic therapy on ventilator associated pneumonia].
    Li H; Yang CH; Tang JG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):60-2. PubMed ID: 21251373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.